By Sabela OjeaBayer said it won a trial over its Roundup weedkiller product liability trial in Philadelphia. "While we have great sympathy for anyone who suffers a loss or injury, science proves that Roundup is not carcinogenic," Bayer said. The company has, however, been ordered to pay billions of dollars in damages over the past few years in cases that alleged Roundup caused cancer. Bayer maintains that Roundup and its main ingredient, glyphosate, is safe to use and has cited reviews by the U.S. Environmental Protection Agency and other regulators that have determined it doesn't pose a cancer risk. Bayer lost the first trial over Roundup's alleged cancer risk in August 2018, shortly after the company completed its $63 billion acquisition of Monsanto, which developed Roundup as well as genetically engineered crops designed to withstand the herbicide.

Source: Wall Street Journal March 06, 2024 12:07 UTC